Medical Devices
Possis announces first human use of GuardDOG occlusion system
Published in Biotech Business Week, January 8th, 2007
Designed to control blood flow through blood vessels during peripheral endovascular procedures, GuardDOG is the industry's first occlusion system to offer a 0.035"-based guidewire with a CO(2)-filled occlusion balloon.
"Our customers have identified the need for a guidewire with a distal occlusion balloon that can easily control blood flow in the vessel while allowing the introduction and use of endovascular treatment tools," said Robert Dutcher, chairman, president and CEO of Possis Medical. "This first human use is the capstone of several years of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Market Analysis
Frost & Sullivan report says airway management devices market will have 7-year stable growth - Market Analysis
Life sciences firms say current documentation practices are inefficient - Market Analysis
Thought leader compensation on the rise at small pharma and biotech companies - Market Analysis
U.K. pharmaceutical and healthcare industry is single-largest user of modern biotechnology - Market Analysis
Wheelchair, scooter market expected to grow to $5.3 billion by 2012, market research shows - Biological Chemistry
Research findings from Amgen, Inc. update understanding of biological chemistry - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
